Search research articles
Contact Us
Filters
Showing results (121-130 of 148) with videos related to
Page
of 15
Sort By:
The British Journal of Nutrition
|
March 8, 2019
Impact of three different daily doses of vitamin D3 supplementation in healthy schoolchildren and adolescents from North India: a single-blind prospective randomised clinical trial
Raman K Marwaha, Mahendra K Garg, Gomathy Sethuraman, et al.
Diabetology & Metabolic Syndrome
|
January 11, 2026
Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: results from the randomized phase 3 PRO-1 trial
Awadhesh Kumar Singh, Krishna G Seshadri, A G Unnikrishnan, et al.
Diabetes, Obesity & Metabolism
|
July 3, 2019
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations
Chaicharn Deerochanawong, Siew P Chan, Bien J Matawaran, et al.
Diabetes Care
|
June 14, 2018
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
Mohammad Shafi Kuchay, Sonal Krishan, Sunil Kumar Mishra, et al.
Diabetes & Metabolism Journal
|
February 26, 2020
Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations
Wayne Huey Herng Sheu, Siew Pheng Chan, Bien J Matawaran, et al.
Diabetes, Obesity & Metabolism
|
November 6, 2020
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations
Chin Meng Khoo, Chaicharn Deerochanawong, Siew Pheng Chan, et al.
Indian Journal of Endocrinology and Metabolism
|
November 13, 2025
Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes: Findings from PIONEER REAL India
Debmalya Sanyal, Banshi Saboo, Sanjeev R Phatak, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 17, 2022
Classical and Nonclassical Manifestations of Primary Hyperparathyroidism
Ghada El-Hajj Fuleihan, Marlene Chakhtoura, Cristiana Cipriani, et al.
Endocrine
|
May 14, 2025
Isovitexin, a natural adiponectin agonist, prevents glucocorticoid-induced osteosarcopenia
Chirag Kulkarni, Saroj Kumar, Shamima Khatoon, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 28, 2019
Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment
Viswanathan Mohan, Kamlesh Khunti, Siew P Chan, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 148) with videos related to
Sort By:
Page
of 15
The British Journal of Nutrition
|
March 8, 2019
Impact of three different daily doses of vitamin D3 supplementation in healthy schoolchildren and adolescents from North India: a single-blind prospective randomised clinical trial
Raman K Marwaha, Mahendra K Garg, Gomathy Sethuraman, et al.
Diabetology & Metabolic Syndrome
|
January 11, 2026
Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: results from the randomized phase 3 PRO-1 trial
Awadhesh Kumar Singh, Krishna G Seshadri, A G Unnikrishnan, et al.
Diabetes, Obesity & Metabolism
|
July 3, 2019
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations
Chaicharn Deerochanawong, Siew P Chan, Bien J Matawaran, et al.
Diabetes Care
|
June 14, 2018
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
Mohammad Shafi Kuchay, Sonal Krishan, Sunil Kumar Mishra, et al.
Diabetes & Metabolism Journal
|
February 26, 2020
Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations
Wayne Huey Herng Sheu, Siew Pheng Chan, Bien J Matawaran, et al.
Diabetes, Obesity & Metabolism
|
November 6, 2020
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations
Chin Meng Khoo, Chaicharn Deerochanawong, Siew Pheng Chan, et al.
Indian Journal of Endocrinology and Metabolism
|
November 13, 2025
Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes: Findings from PIONEER REAL India
Debmalya Sanyal, Banshi Saboo, Sanjeev R Phatak, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 17, 2022
Classical and Nonclassical Manifestations of Primary Hyperparathyroidism
Ghada El-Hajj Fuleihan, Marlene Chakhtoura, Cristiana Cipriani, et al.
Endocrine
|
May 14, 2025
Isovitexin, a natural adiponectin agonist, prevents glucocorticoid-induced osteosarcopenia
Chirag Kulkarni, Saroj Kumar, Shamima Khatoon, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 28, 2019
Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment
Viswanathan Mohan, Kamlesh Khunti, Siew P Chan, et al.
Page
of 15